The DMEC will be housed within the Survey Research Laboratory (SRL) of the University of Illinois at Chicago. SRL was established in 1964 as a research and service division of the University of Illinois to provide survey research services to the faculty, staff, and students of the University of Illinois at Chicago and Urbana-Champaign;other academic institutions;local, state, and federal agencies;and others working in the public interest. SRL has offices on the Chicago and Urbana-Champaign campuses of the University and can undertake complete survey projects from initial study design through data analysis. It also can conduct partial survey work such as sampling, questionnaire design, focus groups, data collection, instrument programming, and data reduction and can provide consultation on survey problems on a fee-for-service basis. Almost since its inception, SRL has had major ongoing programs in survey methodology. In recent years, SRL's methodological research has focused on nonresponse error;questionnaire design and interviewing techniques for collecting hard-to-obtain data;validity and reliability of self- and proxy-reported data;sampling techniques for face-to-face, telephone, and mail surveys, particularly for surveys on sensitive topics and with special populations;and cross-cultural sources of measurement error. Much of this work has focused on health-related subjects, reflecting the interests and expertise of senior research staff. A number of SRL research projects have been supported by federally-funded grants and contracts from the U.S. Bureau of the Census, the Centers for Disease Control and Prevention, the National Center for Health Statistics, the National Institutes of Health (including NCI, NIDA, NIAA, and NIMH), and the National Science Foundation among others. A complete listing of the 1,000+ surveys that have been conducted by SRL can be found by accessing its Web site at www.srl.uic.edu.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA106743-09
Application #
8536601
Study Section
Special Emphasis Panel (ZCA1-SRLB-3)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
9
Fiscal Year
2013
Total Cost
$128,784
Indirect Cost
$58,677
Name
University of Illinois at Chicago
Department
Type
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Hoskins, Kent F; Tejeda, Silvia; Vijayasiri, Ganga et al. (2018) A feasibility study of breast cancer genetic risk assessment in a federally qualified health center. Cancer 124:3733-3741
Warnecke, Richard B; Campbell, Richard T; Vijayasiri, Ganga et al. (2018) A Multilevel Examination of Health Disparity: The Roles of Policy, Neighborhood Context, Patient Resources and Healthcare Facilities in Stage at Diagnosis. Cancer Epidemiol Biomarkers Prev :
E Anderson, Emily; Tejada, Silvia; B Warnecke, Richard et al. (2018) Views of Low-Income Women of Color at Increased Risk for Breast Cancer. Narrat Inq Bioeth 8:53-66
Kresovich, Jacob K; Gann, Peter H; Erdal, Serap et al. (2018) Candidate gene DNA methylation associations with breast cancer characteristics and tumor progression. Epigenomics 10:367-378
Glassgow, Anne Elizabeth; Molina, Yamile; Kim, Sage et al. (2018) A Comparison of Different Intensities of Patient Navigation After Abnormal Mammography. Health Promot Pract :1524839918782168
Molina, Yamile; Kim, Sage J; Berrios, Nerida et al. (2018) Patient Navigation Improves Subsequent Breast Cancer Screening After a Noncancerous Result: Evidence from the Patient Navigation in Medically Underserved Areas Study. J Womens Health (Larchmt) 27:317-323
Peterson, Caryn E; Khosla, Shaveta; Jefferson, Gina D et al. (2017) Measures of economic advantage associated with HPV-positive head and neck cancers among non-Hispanic black and white males identified through the National Cancer Database. Cancer Epidemiol 48:1-7
Molina, Yamile; Glassgow, Anne E; Kim, Sage J et al. (2017) Patient Navigation in Medically Underserved Areas study design: A trial with implications for efficacy, effect modification, and full continuum assessment. Contemp Clin Trials 53:29-35
Rauscher, Garth H; Silva, Abigail; Pauls, Heather et al. (2017) Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities. Breast Cancer Res Treat 163:321-330
Tejeda, Silvia; Gallardo, Rani I; Ferrans, Carol Estwing et al. (2017) Breast cancer delay in Latinas: the role of cultural beliefs and acculturation. J Behav Med 40:343-351

Showing the most recent 10 out of 64 publications